Bayer HealthCare completes the acquisition of Teva's (TEVA +0.1%) U.S.-based animal health...

|About: Teva Pharmaceutical Indus... (TEVA)|By:, SA News Editor

Bayer HealthCare completes the acquisition of Teva's (TEVA +0.1%) U.S.-based animal health business after receiving the necessary regulatory approvals. Teva will receive up to $145M following the achievement of manufacturing and sales targets. The sale is no doubt part of the Israeli company's restructuring.